Key result
HMG-CoA reductase inhibitors improved blood pressure control in hypertensive and hypercholesterolemic patients.
Why the study?
Do HMG-CoA reductase inhibitors improve blood pressure control in hypertensive and hypercholesterolemic patients?
Population
Hypertensive and hypercholesterolemic patients
Authors
Loading...
May support statin consideration for dual benefit in comorbid patients; leaves open confirmation by randomized trials.
Do HMG-CoA reductase inhibitors improve blood pressure control in hypertensive and hypercholesterolemic patients?
HMG-CoA reductase inhibitors may improve blood pressure control in patients with concurrent hypertension and hypercholesterolemia.
Stefano Bacchelli (1998) studied this question. HMG-CoA reductase inhibitors improved blood pressure control in hypertensive and hypercholesterolemic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: